# Precision Medicine With Zibotentan in Microvascular Angina

> **NCT04097314** · PHASE2 · COMPLETED · sponsor: **NHS Greater Glasgow and Clyde** · enrollment: 225 (actual)

## Conditions studied

- Microvascular Angina

## Interventions

- **DRUG:** Zibotentan
- **DRUG:** Placebo oral tablet

## Key facts

- **NCT ID:** NCT04097314
- **Lead sponsor:** NHS Greater Glasgow and Clyde
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-18
- **Primary completion:** 2023-06-08
- **Final completion:** 2023-06-08
- **Target enrollment:** 225 (ACTUAL)
- **Last updated:** 2023-08-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04097314

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04097314, "Precision Medicine With Zibotentan in Microvascular Angina". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04097314. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*